Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization.

Saved in:
Bibliographic Details
Title: Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization.
Authors: Usuda JN; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Plaça DR; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Fonseca DLM; Interunit PostGraduate Program on Bioinformatics, Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil., Marques AHC; Departament of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Filgueiras IS; Departament of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Chaves VGB; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Adri AS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Torrentes-Carvalho A; Departament of Immunobiology, Institute of Biology, Federal Fluminense University, Niterói, Brazil., Hirata MH; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Freire PP; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.; Departament of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Catar R; Departament of Nephrology and Internal Intensive Care Medicine, Charité University Hospital, Berlin, Germany., Cabral-Miranda G; Departament of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil., Schimke LF; Departament of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Department of Medicine, Division of Molecular Medicine, University of São Paulo School of Medicine, São Paulo, Brazil.; Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, São Paulo, Brazil., Moll G; Departament of Nephrology and Internal Intensive Care Medicine, Charité University Hospital, Berlin, Germany., Cabral-Marques O; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.; Interunit PostGraduate Program on Bioinformatics, Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil.; Departament of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Department of Medicine, Division of Molecular Medicine, University of São Paulo School of Medicine, São Paulo, Brazil.; Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, São Paulo, Brazil.; Network of Immunity in Infection, Malignancy, Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), São Paulo, SP, Brazil.
Source: Frontiers in immunology [Front Immunol] 2023 Aug 10; Vol. 14, pp. 1243516. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).
Publication Type: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1243516